Literature DB >> 31261329

The Efficacy of Hyaluronidase in Early Surgery of Nasal Bone Fracture.

Joo-Hak Kim1, Heesang Yang, Sang-Ha Oh, Seung Han Song, Hyunwoo Kyung.   

Abstract

A nasal bone fracture is one of the most common facial injuries and is often treated by closed reduction. Typically, 2 to 3 weeks are needed for patients to return to daily life because the operation is performed after swelling around the fracture site is reduced. This study aimed to investigate that hyaluronidase injection could reduce swelling, perform early operation and return to daily life accelerated.From January 2017 to December 2017, 181 patients with nasal bone fracture were analyzed. 60 patients underwent hyaluronidase injection and massage to reduce edema, then performed surgery within 2 to 4 days. The remaining patients were treated conservatively (massage alone); they then underwent surgery. Ultrasonography was used to measure changes in skin thickness, and the treatment duration, outcome, and patient satisfaction were compared.The duration from injury to surgery was short in the early operation group, and the period of recovery and return to ordinary life was significantly shorter than in the conventional group. The difference in skin thickness after hyaluronidase injection and massage was 0.8 mm in the early operation group; there was no significant difference in the conventional group. There was no statistically significant difference in satisfaction between the 2 groups, but the mean satisfaction was higher in the early operation group.In patients with nasal bone fracture after facial trauma, hyaluronidase injection, and massage led to reduced edema. This might improve patient satisfaction by allowing earlier operation and earlier return to daily life.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31261329     DOI: 10.1097/SCS.0000000000005646

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  1 in total

1.  Efficacy of local hyaluronidase administration in guided bone regeneration surgery: a randomized controlled trial.

Authors:  Min-Jeong Kwoen; Yong-Hoon Choi; Keun-Suh Kim; Na-Hee Chang; Young-Kyun Kim; Hyo-Jung Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2021-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.